Accounting & Financial Management
Medicare annual spending on lecanemab's medication costs alone would place it among the most expensive Part B medications.
Even conditions with a low average cost, such as behavioral health and orthopedic issues, can reach over $1 million, data shows.
HIMSS23
<p>Dr. Jay Bhatt, managing director at Deloitte, said healthcare is more than just about access: It's a business imperative that requires business solutions.</p>
HIMSS23
<p>R David Moon, chairman and founder of Arx Nimbus, said point solutions encourage a reactive approach to cyber threats, and that a proactive approach to risk is needed.</p>
<p> </p>
While the plan fell short of Oscar Health's expectations, CEO Bertolini noted that the company did turn a profit in the first quarter.
UnitedHealth Group's other core segment, UnitedHealthcare, saw revenues grow 13% to $70.5 billion.
An Independent Special Committee will review options, ranging from potential sale to recapitalization or partnerships.
The company pledges more transparency around its PBM business, run through the Evernorth subsidiary.
There is "inbound interest" in the California MA business, which is strong and serving 125,000 seniors, says board of directors.
Medicaid contracts also grew earnings for the business, which no longer includes employer group commercial medical.